Insider Trading & Ownership - Scott Kathleen D.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Scott Kathleen D.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-10-16
Sale
2024-10-17
4:30 pm
ARS Pharmaceuticals Inc.SPRYScott Kathleen D.
Chief Financial Officer
12,500$16$200,000815,529
(Indirect
Direct)
View
2024-08-20
Sale
2024-08-21
6:49 pm
ARS Pharmaceuticals Inc.SPRYScott Kathleen D.
Chief Financial Officer
12,500$16$200,000828,029
(Direct)
View
2022-11-29
Purchase
2022-12-01
4:31 pm
ARS Pharmaceuticals Inc.SPRYScott Kathleen D.
Chief Financial Officer
8,250$6.2432$51,5068,250
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-10-16
Exercise
2024-10-17
4:30 pm
N/A
N/A
ARS Pharmaceuticals Inc.SPRYScott Kathleen D.
Chief Financial Officer
12,500$1.5815,529
(Direct)
View
2024-10-16
Exercise
2024-10-17
4:30 pm
N/A
2032-02-29
ARS Pharmaceuticals Inc.SPRYScott Kathleen D.
Chief Financial Officer
12,500$0815,529
(Direct)
View
2024-08-20
Exercise
2024-08-21
6:49 pm
N/A
N/A
ARS Pharmaceuticals Inc.SPRYScott Kathleen D.
Chief Financial Officer
12,500$1.5828,029
(Direct)
View
2024-08-20
Exercise
2024-08-21
6:49 pm
N/A
2032-02-29
ARS Pharmaceuticals Inc.SPRYScott Kathleen D.
Chief Financial Officer
12,500$0828,029
(Direct)
View
2024-02-12
Option Award
2024-02-14
8:20 pm
N/A
N/A
NKGen Biotech Inc.NKGNScott Kathleen D.
Director
300,000$0300,000
(Direct)
View
2024-01-04
Option Award
2024-01-05
9:01 pm
N/A
2034-01-03
Dermata Therapeutics Inc.DRMAScott Kathleen D.
Director
10,000$010,000
(Direct)
View
2024-01-02
Option Award
2024-01-04
4:39 pm
N/A
2034-01-01
ARS Pharmaceuticals Inc.SPRYScott Kathleen D.
Chief Financial Officer
200,000$0200,000
(Direct)
View
2023-01-03
Option Award
2023-01-05
5:00 pm
N/A
2033-01-02
ARS Pharmaceuticals Inc.SPRYScott Kathleen D.
Chief Financial Officer
50,000$050,000
(Direct)
View
2022-11-08
Option Award
2022-11-10
6:00 pm
N/A
2032-03-01
ARS Pharmaceuticals Inc.SPRYScott Kathleen D.
Chief Financial Officer
827,330$0827,330
(Direct)
View
2022-10-06
Option Award
2022-10-07
5:05 pm
N/A
N/A
Dermata Therapeutics Inc.DRMAScott Kathleen D.
Director
11,359$029,584
(Direct)
View
2022-07-07
Option Award
2022-07-08
4:10 pm
N/A
N/A
Dermata Therapeutics Inc.DRMAScott Kathleen D.
Director
9,960$018,225
(Direct)
View
2022-04-07
Option Award
2022-04-08
7:17 pm
N/A
N/A
Dermata Therapeutics Inc.DRMAScott Kathleen D.
Director
5,826$08,265
(Direct)
View
2022-01-03
Option Award
2022-01-05
7:05 pm
N/A
2032-01-02
Dermata Therapeutics Inc.DRMAScott Kathleen D.
Director
5,000$05,000
(Direct)
View
2021-08-17
Option Award
2021-08-17
12:47 pm
N/A
2031-08-17
Dermata Therapeutics Inc.DRMAScott Kathleen D.
Director
10,000$010,000
(Direct)
View

Ownership
2021-08-12
7:47 pm
N/A
N/A
Dermata Therapeutics Inc.DRMAScott Kathleen D.
Director
0$02,439
(Indirect)
View
2019-11-18
Option Award
2019-11-19
4:10 pm
N/A
2029-11-17
Conatus Pharmaceuticals Inc.CNATScott Kathleen D.
Director
30,000$030,000
(Direct)
View